Comprehensive Analysis Reveals the Potential Roles of CDKN3 in Pancancer and Verification in Endometrial Cancer
Chao Gao, Xiangqin Fan, Yanyan Liu, Yanyan Han, Shiqi Liu, Huanrong Li, Qiaoling Zhang, Yingmei Wang, Fengxia Xue · 2023
Read Comprehensive Analysis Reveals the Potential Roles of CDKN3 in Pancancer and Verification in Endometrial Cancer by Chao Gao, Xiangqin Fan, Yanyan Liu, Yanyan Han, Shiqi Liu, Huanrong Li, Qiaoling Zhang, Yingmei Wang, Fengxia Xue (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10723185.txt.
Description
Chao Gao and co-authors analyze a cell cycle gene across cancers in a 2023 study. The gene, CDKN3, had been studied cancer by cancer, but no full pan cancer map existed. Public data were mined for its expression, gene changes, and links to survival, signaling pathways, and drug response across tumor types.
The gene ran high in most cancers, and high levels tied to worse survival. It also tracked with immune related pathways and could flag which drugs a tumor may answer to. Lab checks confirmed high levels in womb lining cancer tissue, and cell tests showed it speeds growth and cell cycle entry while shaping the immune setting. The authors propose it as a new marker.
Catalog record
| CREATOR | Chao Gao, Xiangqin Fan, Yanyan Liu, Yanyan Han, Shiqi Liu, Huanrong Li, Qiaoling Zhang, Yingmei Wang, Fengxia Xue |
|---|---|
| YEAR | 2023 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 52 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |